Enwei Xu
Shanxi Medical University
27 Papers
16 Citations
Enwei Xu is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 9, co-authored 14 publications.
Chat about Author
Papers
Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
Ling Zhang,Yong Zhou,Caixia Cheng,Heyang Cui,Le Cheng,Pengzhou Kong,Jiaqian Wang,Yin Li,Wenliang Chen,Bin Song,Fang Wang,Zhiwu Jia,Lin Li,Yaoping Li,Bin Yang,Jing Liu,Ruyi Shi,Yanghui Bi,Yanyan Zhang,Juan Wang,Zhenxiang Zhao,Xiaoling Hu,Jie Yang,Hongyi Li,Zhibo Gao,Gang Chen,Xuanlin Huang,Xukui Yang,Shengqing Wan,Chao Chen,Bin Li,Yongkai Tan,Chen Longyun,Minghui He,Sha Xie,Xiangchun Li,Xuehan Zhuang,Mengyao Wang,Zhi Xia,Longhai Luo,Jie Ma,Bing Dong,Jiuzhou Zhao,Yongmei Song,Yunwei Ou,Enming Li,Li-Yan Xu,Jinfen Wang,Yanfeng Xi,Guodong Li,Enwei Xu,Jianfang Liang,Xiaofeng Yang,Jiansheng Guo,Xing Chen,Yanbo Zhang,Qingshan Li,Lixin Liu,Yingrui Li,Xiuqing Zhang,Huanming Yang,Dongxin Lin,Xiaolong Cheng,Yongjun Guo,Jun Wang,Qimin Zhan,Yongping Cui +66 more
TL;DR: High activity of hedgehog signaling and the PI3K pathway in approximately 60% of 104 ESCC tumors indicates that therapies targeting these pathways might be particularly promising strategies for ESCC.
323
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.
Yongping Cui,Hongyan Chen,Ruibin Xi,Heyang Cui,Heyang Cui,Yahui Zhao,Enwei Xu,Ting Yan,Xiaomei Lu,Furong Huang,Pengzhou Kong,Li Yang,Xiaolin Zhu,Jiawei Wang,Wenjie Zhu,Jie Wang,Yanchun Ma,Yong Zhou,Yong Zhou,Shiping Guo,Ling Zhang,Ling Zhang,Yiqian Liu,Yiqian Liu,Bin Wang,Yanfeng Xi,Ruifang Sun,Xiao Yu,Yuanfang Zhai,Yuanfang Zhai,Fang Wang,Jian Yang,Bin Yang,Caixia Cheng,Jing Liu,Bin Song,Hongyi Li,Yi Wang,Yi Wang,Yingchun Zhang,Yingchun Zhang,Xiaolong Cheng,Qimin Zhan,Qimin Zhan,Yanhong Li,Zhihua Liu +45 more
TL;DR: The largest dataset of genomic profiling of ESCC is reported useful for developing ESCC-specific biomarkers for diagnosis and treatment and found clinically relevant coding and noncoding genomic alterations and revealed three major subtypes that robustly predicted patients’ outcomes.
207
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
Caixia Cheng,Yong Zhou,Hongyi Li,Teng Xiong,Shuai Cheng Li,Yanghui Bi,Pengzhou Kong,Fang Wang,Heyang Cui,Yaoping Li,Xiaodong Fang,Ting Yan,Yike Li,Juan Wang,Bin Yang,Ling Zhang,Zhiwu Jia,Bin Song,Xiaoling Hu,Jie Yang,Haile Qiu,Gehong Zhang,Jing Liu,Enwei Xu,Ruyi Shi,Yanyan Zhang,Haiyan Liu,Chanting He,Zhenxiang Zhao,Yu Qian,Ruizhou Rong,Zhiwei Han,Yanlin Zhang,Wen Luo,Jiaqian Wang,Shaoliang Peng,Xukui Yang,Xiangchun Li,Lin Li,Hu Fang,Xingmin Liu,Li Ma,Yunqing Chen,Shiping Guo,Xing Chen,Yanfeng Xi,Guodong Li,Jianfang Liang,Xiaofeng Yang,Jiansheng Guo,JunMei Jia,Qingshan Li,Xiaolong Cheng,Qimin Zhan,Yongping Cui +54 more
TL;DR: This work re-analyzed whole-genome sequencing data from 31 ESCCs using Meerkat algorithm to predict somatic SVs and Patchwork to determine copy-number changes and found deletions and translocations with NHEJ and alt-EJ signature as the dominant SV types, and 16% of deletions were complex deletions.
130
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.
Zhihua Liu,Yahui Zhao,Pengzhou Kong,Yuhao Liu,Jing Huang,Enwei Xu,Wenqing Wei,Guangyu Li,Xiaolong Cheng,Liyan Xue,Yi Li,Hongyan Chen,Shuqing Wei,Ruifang Sun,Heyang Cui,Yongsheng Meng,Meilin Liu,Yang Li,R. Feng,Xiao Yu,Rui Zhu,Yenan Wu,Lei Li,Bin Yang,Yanchun Ma,Jiawei Wang,Wenshuai Zhu,Dongmei Deng,Yanfeng Xi,Fang Wang,Hongyi Li,Shiping Guo,Xiaofei Zhuang,Xiaoyue Wang,Yuchen Jiao,Yongping Cui,Qimin Zhan +36 more
TL;DR: Wang et al. as discussed by the authors analyzed the whole genomic, epigenomic, transcriptomic, and proteomic data of 155 esophageal squamous cell carcinomas (ESCCs) and developed a classifier with 28 features to identify the IM subtype, which predicted anti-PD-1 therapy response with 85.7% sensitivity and 90% specificity.
82
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma.
Yanghui Bi,Pengzhou Kong,Ling Zhang,Heyang Cui,Xiaoqin Xu,Feiyun Chang,Ting Yan,Jiayi Li,Caixia Cheng,Bin Song,Xia Niu,Xiangchen Liu,Xue Liu,Enwei Xu,Xiaoling Hu,Yu Qian,Fang Wang,Hongyi Li,Yanchun Ma,Jian Yang,Yiqian Liu,Yuanfang Zhai,Yi Wang,Yingchun Zhang,Haiyan Liu,Jing Liu,Jintao Wang,Yongping Cui,Xiaolong Cheng +28 more
TL;DR: This study identified a novel role and mechanism of EP300 in ESCC, provided epigenetic therapeutic strategies for the treatment of ESCC and found that EP300 knockdown led to inhibition of cell proliferation, colony formation, migration and invasion.